Editorial comment

Active surveillance is a widely embraced option for men with low-risk prostate cancer who wish to avoid immediate therapy and its associated morbidity.1 Unfortunately, a number of these men will harbor more aggressive disease at diagnosis that will go unrecognized and the opportunity for curative therapy may be delayed or missed altogether. The advent of multiparametric MRI in the evaluation of these men has offered better initial risk stratification. A number of recent trials have demonstrated reasonable positive predictive value in the detection of clinically significant disease.
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research